XML 25 R15.htm IDEA: XBRL DOCUMENT
v3.25.2

Note 6 - Goodwill and Intangible Assets | 9 Months Ended
--- | ---
Jun. 30, 2025
Notes to Financial Statements |
Goodwill and Intangible Assets Disclosure [Text Block] | 6. Goodwill and Intangible Assets The Company conducts an impairment assessment annually on April 1, or more frequently if impairment indicators are present. The Company determined that a sustained decline in its stock price was an indicator of potential impairment and performed an interim quantitative goodwill impairment test for its reporting units as of June 30, 2025. Based on the results of the interim quantitative impairment test performed as of June 30, 2025, the fair values of the Sample Management Solutions (“SMS”) and Multiomics reporting units exceeded their respective carrying amounts. The Company concluded that there was no impairment to goodwill for the SMS and Multiomics reporting units as of June 30, 2025. The estimated fair value of each of the reporting units was derived based on the income approach and the market approach which were weighted at 75% and 25%, respectively, as of June 30, 2025. The DCF Method was used in the income approach which reflected the Company’s assumptions regarding revenue growth rates, forecasted gross profit margins, operating expenses, capital expenditures, discount rates, terminal period growth rates, economic and market trends, and other expectations about the anticipated operating results of the SMS and Multiomics reporting units. The guideline company method was used in the market approach and publicly traded companies in similar lines of business were identified and used in an analysis to estimate the fair value. Prior to the quantitative goodwill impairment test, the Company tested the recoverability of long-lived assets and other assets of the SMS and Multiomics reporting units and concluded that such assets were not impaired as of June 30, 2025. ​The following table sets forth the changes in the carrying amount of goodwill by operating and reportable segment since September 30, 2024 (in thousands). ​
|  | Sample |  |  |  |  |  |  |  |  |
​ |  | Management |  |  |  |  |  |  |  |  |
|  | Solutions |  |  | Multiomics |  |  | Total |
Balance - October 1, 2024 |  | $ | 494,649 |  |  | $ | 196,760 |  |  | $ | 691,409 |
Currency translation adjustments |  |  | 12,205 |  |  |  | — |  |  |  | 12,205 |
Balance - June 30, 2025 |  | $ | 506,854 |  |  | $ | 196,760 |  |  | $ | 703,614 |
The components of the Company’s identifiable intangible assets as of June 30, 2025 and September 30, 2024 are as follows (in thousands):
​ |  | June 30, 2025 |  |  | September 30, 2024 |
​ |  | ​ |  |  | Accumulated |  |  | Net Book |  |  | ​ |  |  | Accumulated |  |  | Net Book |
​ |  | Cost |  |  | Amortization |  |  | Value |  |  | Cost |  |  | Amortization |  |  | Value |
Patents |  | $ | 1,220 |  |  | $ | 1,220 |  |  | $ | — |  |  | $ | 1,227 |  |  | $ | 1,227 |  |  | $ | — |
Completed technology |  |  | 111,681 |  |  |  | 61,411 |  |  |  | 50,270 |  |  |  | 109,949 |  |  |  | 55,191 |  |  |  | 54,758 |
Trademarks and trade names |  |  | 734 |  |  |  | 271 |  |  |  | 463 |  |  |  | 726 |  |  |  | 195 |  |  |  | 531 |
Customer relationships |  |  | 249,203 |  |  |  | 191,800 |  |  |  | 57,403 |  |  |  | 248,036 |  |  |  | 178,283 |  |  |  | 69,753 |
Total |  | $ | 362,838 |  |  | $ | 254,702 |  |  | $ | 108,136 |  |  | $ | 359,938 |  |  | $ | 234,896 |  |  | $ | 125,042 |
Amortization expenses for intangible assets were $6.2 million and $7.2 million, respectively, for the three months ended June 30, 2025 and 2024. Amortization expenses for intangible assets were $18.4 million and $21.6 million, respectively, for the nine months ended June 30, 2025 and 2024. Estimated future amortization expense for the intangible assets for the remainder of fiscal year 2025 and the subsequent five fiscal years are as follows (in thousands):
Remainder of fiscal year 2025 |  | $ | 6,239 |
2026 |  |  | 22,315 |
2027 |  |  | 17,887 |
2028 |  |  | 15,003 |
2029 |  |  | 12,386 |
2030 |  |  | 10,811 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-30/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-20/tableOfContent + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration